metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Factores predictivos de la recidiva de cáncer colorrectal
Información de la revista
Vol. 70. Núm. 6.
Páginas 267-273 (diciembre 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 70. Núm. 6.
Páginas 267-273 (diciembre 2001)
Acceso a texto completo
Factores predictivos de la recidiva de cáncer colorrectal
Predictive factors for colorectal cancer recurrence
Visitas
4904
F. García-Anguianoa
Autor para correspondencia
fidelgad@teleline.es

Correspondencia: Dr. F. García-Anguiano Duque. Carvajal, 2, 1.° E. 35004 Las Palmas de Gran Canaria
, J. Marchena, J.A. Martín, G. Gómez, E. Nogués
Servicio de Cirugía General y Digestiva
J. Hernández*
* Jefe de Servicio. Hospital de Gran Canaria Dr. Negrín. Las Palmas de Gran Canaria
Este artículo ha recibido
Información del artículo
Resumen
Introducción

El seguimiento estrecho y no selectivo de todos los pacientes intervenidos de cáncer colorrectal (CCR) supone un gran consumo de recursos y tiempo, cuya necesidad se ha cuestionado. Sería ideal conocer a priori a aquellos pacientes con mayor probabilidad de recidiva que serían los que verdaderamente se van a beneficiar de una estrecha vigilancia.

Objetivos

Definir una población de alto riesgo de recidiva de CCR según parámetros comúnmente empleados en la clínica y laboratorio.

Pacientes y método

Estudio retrospectivo, descriptivo y longitudinal de 398 pacientes intervenidos de CCR en nuestra institución entre 1988 y 1995. Se recogieron los datos correspondientes a filiación, antecedentes personales, síntomas clínicos relevantes (masa palpable, anemia, perforación, oclusión); datos de laboratorio; marcadores tumorales, localización del tumor, tipo y carácter de la intervención, estadio TNM, grado de diferenciación, presencia de mucina, transfusiones perioperatorias, complicaciones postoperatorias, infecciones, recidiva y supervivencia libre de enfermedad. El tiempo medio de seguimiento fue de 33,6 meses. Se analizó la relación de estas variables con la supervivencia libre de recidiva mediante el test de rangos logarítmicos. Posteriormente, se introdujeron las variables significativas en un modelo de regresión de Cox para determinar los factores pronósticos independientes que se relacionaban con la recidiva.

Resultados

La muestra estudiada constaba de 398 pacientes, 204 varones (51,4%) y 194 mujeres (48,7%); edad media: 65,30 años (rango: 21-91) (DE: 13,46; IC del 95%: 63,98-66,63). Recidivaron 85 pacientes (21,4%), siendo la probabilidad de estar libre de recidiva a los 5 años del 63,47%. En el análisis bivariante se relacionaron con la recidiva de forma estadísticamente significativa los siguientes parámetros: edad (p = 0,007); clínica de complicación (perforación/ oclusión) (p = 0,009); valores de GGT (p = 0,02); CEA alterado (p = 0,04); localización rectal (p = 0,03); cirugía urgente (p = 0,01); penetración transmural (p = 0,001); ganglios afectados (p = 0,0001) y absceso de pared (p = 0,0005). El resto de los parámetros no se relacionó con la recidiva. En el análisis multivariante permanecieron como factores predictivos independientes los siguientes: edad (p = 0,02; OR = 0,98); valores de GGT (p = 0,001; OR = 3,15); localización en recto (p = 0,04; OR = 2,03); absceso de pared (p = 0,04; OR = 1,9), y afección ganglionar (p = 0,0001; OR = 4,72).

Conclusiones

La identificación de una población de alto riesgo de recidiva tumoral podría permitir un seguimiento postoperatorio más selectivo con vistas a disminuir recursos y costes.

Palabras clave:
Cáncer colorrectal
Recidiva
Factores predictivos
Introduction

Close, non-selective postoperative follow- up of patients with colorectal cancer involves high resource use and is time-consuming and its necessity has been questioned. Patients at high risk of recurrence could be identified and undergo close surveillance.

Aim

To define a population at high risk for colorectal cancer recurrence based on commonly used clinical, laboratory and histologic parameters.

Patients and method

Retrospective, descriptive and longitudinal study of 398 patients who underwent surgery for colorectal neoplasm in our hospital between 1988 and 1995. Data on familial and personal antecedents, relevant clinical symptoms (palpable mass, anemia, perforation, occlusion), laboratory tests, tumoral markers, tumoral localization, type of surgery, tumor-node-metastasis classification, histologic grade of differentiation, presence of mucin, perioperative transfusions, postoperative complications, infections, recurrence and disease-free survival were recorded. Mean follow-up was 33.6 months. To determine the relationship between these variables and disease-free survival bivariate analysis using the Logrank test was performed. To determine the independent prognostic factors associated with recurrence, significant variables were subsequently introduced in multivariate analysis using Cox regression model.

Results

The sample consisted of 398 patients; 204 (51.4%) men and 194 (48.7%) women. Mean age was 65.3 years (21-91 years) (SD: 13.46; 95% CI: 63.98- 66.63 years). Eighty five patients (21.4%) relapsed. The probability of disease-free survival at 5 years was 63.47%. In the bivariate analysis the following variables showed a statistically significant association with recurrence: age (p = 0.007, clinical complications (perforation or obstruction) (p = 0.009); gamma-glutamyl transferase (GGT) levels (p = 0.02); alterations in carcinoembryonic antigen levels (p = 0.04); localization in the rectum (p = 0.03); emergency surgery (p = 0.01); wall penetration (p = 0.001); ganglionic node involvement (p = 0.0001) and wall abscess (p = 0.0005). No relationship was found between the remaining variables and recurrence. In the multivariate analysis independent prognostic factors were age (p = 0.02; OR = 0.98); GGT levels (p = 0.001; OR = 3.15); localization in the rectum (p = 0.04; OR: 2.03); wall abscess (p = 0.04; OR = 1.9) and ganglionic node involvement (p = 0.0001; OR: 4.72).

Conclusions

Identification of patients at high risk for recurrence could allow more selective postoperative follow-up, thus reducing resource use and costs.

Key words:
Colorectal cancer
Recurrence
Predictive factors
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.R. Jass.
Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983.
Dis Colon Rectum, 34 (1991), pp. 56-59
[2.]
E. Navascués, J. Devesa.
Seguimiento del cáncer rectal tras resección curativa: resultados de una década.
Cir Esp, 54 (1993), pp. 144-149
[3.]
A.R. Moosa, P.C. Ree, J.E. Marks, B. Levin, C.E. Platz, D.B. Skinner.
Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid.
Br J Surg, 62 (1975), pp. 727-730
[4.]
S. Rinnert-Gongora, P.L. Tartter.
Multivariate analysis of recurrence after anterior resection for col orectal carcinoma.
Am J Surg, 157 (1989), pp. 573-576
[5.]
P.H. Chapuis, O.F. Dent, R. Fisher, R.C. Newland, M.T. Pheils, E. Smyth, et al.
A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer.
Br J Surg, 72 (1985), pp. 698-702
[6.]
M. Ponz de Leon, M. Sant, A. Micheli, C. Sacchetti, C. Di Gregorio, R. Fante, et al.
Clinical and patologic prognostic indicators in colorectal cancer. A Population based study.
Cancer, 69 (1992), pp. 626-635
[7.]
P.G. Gill, P.J. Morris.
The survival of patients with colorectal cancer treated in a regional hospital.
Br J Surg, 65 (1978), pp. 17-20
[8.]
T.B. Halvorsen, E. Seim.
Influence of mucinous components on survival in colorectal adenocarcinoma: a multivariate analysis.
J Clin Pathol, 41 (1988), pp. 1068-1072
[9.]
P. Durdey, N.S. Williams.
The effect of malignant and inflammatory fixation of rectal carcinoma on prognosis after rectal excision.
Br J Surg, 71 (1984), pp. 787-790
[10.]
H.C. Umpleby, R.C. Williamson.
Large bowel cancer in the young.
Ann Acad Med, 16 (1987), pp. 456-461
[11.]
P.M. Griffin, J.M. Liff, R.S. Greenberg, W.S. Clark.
Adenocarcinomas of the colon and rectum in persons under 40 years old: a populationbased study.
Gastroenterology, 100 (1991), pp. 1033-1040
[12.]
F. García-Anguiano, J. Marchena, J.A. Aguiar, A. Conde, F. Cruz.
El cáncer colorrectal en el contexto de las neoplasias primarias malignas múltiples.
Rev Esp Enf Digest, 87 (1995), pp. 369-374
[13.]
V.S. Swaroop, S.J. Winawer, R.C. Kurtz, M. Lipkin.
Multiple primary malignant tumors.
Gastroenterology, 93 (1987), pp. 779-783
[14.]
J.H. Anderson, D. Hole, C.S. McArdle.
Elective versus emergency surgery for colorectal cancer.
Br J Surg, 79 (1992), pp. 706-709
[15.]
A.E. Chang, E.G. Schaner, D.M. Conkle, M.W. Flye, J.L. Doppmann, S.A. Rosemberg.
Evaluation of computed tomography in the detection of pulmonary metastases.
Cancer, 43 (1979), pp. 913-916
[16.]
E. Tobaruela, J. Camuñas, J.M. Enríquez-Navascues, M. Díez, T. Ratia, A. Martín, et al.
Factores médicos que influyen en la morbilidad y la mortalidad en pacientes operados de urgencia de cáncer colorrectal.
Rev Esp Enferm Dig, 89 (1997), pp. 13-22
[17.]
E.L. Bokey, P.H. Chapius, O.F. Dent, R.C. Newland, S.J. Koorey, P.J. Zelas, et al.
Factors affecting survival after excision of the rectum for cancer.
Dis Colon Rectum, 40 (1997), pp. 3-10
[18.]
C.S. McArdle, D. Hole.
Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.
BMJ, 302 (1991), pp. 1501-1505
[19.]
R.K.S. Phillips.
Adequate distal margin of resection for adenocarcinoma of the rectum.
World J Surg, 16 (1992), pp. 463-466
[20.]
S.M. Steinberg, J.S. Barkin, R.S. Kaplan, D.M. Stablein.
Prognostic indicators of colon tumors.
Cancer, 57 (1986), pp. 1866-1870
[21.]
F. Glenn, C.K. McSherry.
Obstruction and perforation in colorectal cancer.
Ann Surg, 173 (1971), pp. 983-992
[22.]
C. Ratto, L. Sofo, M. Ippoliti, M. Merico, G.B. Doglietto, F. Crucitti.
Prognostic factors in colorrectal cancer.
Dis Colon Rectum, 41 (1998), pp. 1033-1049
[23.]
J.P. Weich, G.A. Donaldson.
Management of severe obstruction of the large bowel due to malignant disease.
Am J Surg, 127 (1974), pp. 492-499
[24.]
W.C. Willet, J.E. Tepper, A. Cohen, E. Orlow, C. Weich.
Obstructive and perforative colonic carcinoma: patterns of failure.
J Clin Oncol, 3 (1985), pp. 379-384
[25.]
F. Crucitti, L. Sofo, G.B. Doglietto, R. Bellamonte, C. Ratto, M. Bossola, et al.
Prognostic factors in colorectal cancer: Current status and new trends.
J Surg Oncol, 2 (1991), pp. 76-82
[26.]
M.R. Griffin, E.J. Bergstralh, R.J. Coffey, R.W. Beart, L.J. Melton.
Predictors of survival after curative resection of carcinoma of the colon and rectum.
Cancer, 60 (1987), pp. 2318-2324
[27.]
D. Albanes, D.Y. Jones, A. Schatzkin, M.S. Micozzi, P.R. Taylor.
Adult stature and risk of cancer.
Cancer Res, 48 (1988), pp. 1658-1662
[28.]
L.P. Fielding, R.K. Phillips, J.S. Fry, R. Hittinger.
Prediction of outcome after curative resection for large bowel cancer.
Lancet, 18 (1986), pp. 904-906
[29.]
P. García-Péche, A. Vásquez-Prado, R. Fabra-Ramis, R. Trullenque-Peris.
Factors of prognostic value in long-term survival of colorectal cancer patients.
Hepatogastroenterology, 38 (1991), pp. 438-443
[30.]
P. Lasser, H. Mankarios, D. Elias, C. Bognel, F. Eschewege, P. Wibaul, et al.
Etude pronostique uni et multi-factorielle de 400 adenocarcinomes rectaux reseques.
J Chir, 2 (1993), pp. 57-65
[31.]
J.C. García-Valdecasas, J.M. Lloveras, A.M. DeLacy, J.C. Reverter, J.L. Grande, J. Fuster, et al.
Obstructing colorectal carcinomas. Prospective study.
Dis Colon Rectum, 34 (1991), pp. 759-762
[32.]
A. Amato, M. Pescatori.
Effect of perioperative blood transfusions on recurrence of colorrectal cancer. Metaanalysis.
Dis Colon Rectum, 41 (1998), pp. 570-585
[33.]
P.R. Band, I.T. Beck, P.J. Dinner, B.C. Lentle, R. Amy.
Two years followup study of patients with known serum concentrations of carcinoembryonic antigen.
Can Med Assoc J, 117 (1977), pp. 657-659
[34.]
W.Y. Chang, W.E. Burnett.
Complete colonic obstruction due to adenocarcinoma.
Surg Gynecol Obstet, 114 (1962), pp. 353-356
[35.]
J.T. Evans, A. Mittelman, M. Chu, E.D. Holyoke.
Pre and postoperative uses of CEA.
Cancer, 42 (1978), pp. 1419-1421
[36.]
H.J. Staab, F.A. Anderer, E. Stump, A. Hornung, R. Fisher, G. Keininger.
Eighty-four potential second-look operations based on sequential CEA determinations and clinical investigations in patients with recurrent gastrointestinal cancer.
Am J Surg, 149 (1985), pp. 198-204
[37.]
M. Onetto, M. Paganuzzi, G.B. Secco, R.L. Momparler, L.F. Momparler, G.E. Riverd.
Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
Biomed Pharmacother, 39 (1985), pp. 392-395
[38.]
J.J. Szymendera, M.P. Nowacki, A.W. Szalowski, J.A. Kaminska.
Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma.
Dis Col Rectum, 25 (1982), pp. 46-52
[39.]
K.E. Blake, M.H. Dalbow, J.P. Concannon, S.E. Hodgson, G.J. Brodmarkel Jr., A.H. Panahadeh, et al.
Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel.
Dis Colon Rectum, 25 (1982), pp. 24-32
[40.]
H. Lewi, L.H. Blumgart, D.C. Carter, C.R. Gillis, D. Hole, J.G. Ractliffe, et al.
Pre-operative carcinoembryonic antigen and survival in patients with colorectal cancer.
Br J Surg, 71 (1984), pp. 206-208
[41.]
X. Albe, P. Vassilakos, K. Helfer-Guamori, J.C. Givel, N. De Quay, C. Suardet, et al.
Independent prognostic value of ploidy in colorectal cancer.
Cancer, 66 (1990), pp. 1168-1175
[42.]
J.P. Arnaud, C. Koehl, M. Adolff.
Carcinoembryonic antigen in the diagnosis and prognosis of colorectal carcinoma.
Dis Colon Rectum, 23 (1980), pp. 141-144
[43.]
P. Laurent-Puig, S. Olschwang, O. Delattre, Y. Renvikos, B. Asselain, T. Melot, et al.
Survival and acquired genetic alterations in colorectal cancer.
Gastroenterology, 102 (1992), pp. 1136-1141
[44.]
N.A. Scott, H.S. Wieland, C.G. Moertel, S.S. Cha, R.W. Beart, M.M. Lieber.
Colorectal cancer: Dukes stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Arch Surg, 122 (1987), pp. 1375-1379
[45.]
S.F. Sener, J.P. Imperato, J. Chmiel, A. Fremgen, J. Sylvester.
The use of cancer register data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer.
CA, 6 (1989), pp. 3951-3955
[46.]
J.C. Goligher.
Surgery of the anus, rectum and colon.
Surgery of the anus, rectum and colon,
[47.]
E. Pellicer, P. Parrilla, D. García, G. Morales, J. Ruiz.
Factores pronósticos del cáncer colorrectal. Estudio en una serie de 689 casos.
Cir Esp, 54 (1993), pp. 320-323
[48.]
E.C. Vanvakas.
Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation.
Transfusion, 35 (1995), pp. 760-768
[49.]
A.V. Juberth, E.T. Lee, E.M. Hresch, C.M. McBride.
Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.
J Surg Res, 15 (1973), pp. 399-403
[50.]
W.B. Ross.
Blood transfusion and prognosis in colorectal cancer.
N Engl J Med, 329 (1993), pp. 1354-1358
[51.]
A.M. Akyol, J.R. McGregor, D.J. Galloway, G. Murray, W.D. George.
Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence?.
Int J Colorectal Dis, 6 (1991), pp. 179-183
[52.]
D.A. Symonds, A.L. Vickery Jr..
Mucinous carcinoma of the colon and rectum.
Cancer, 37 (1976), pp. 1891-1900
[53.]
H.C. Umpleby, D.L. Ranson, R.C. Williamson.
Peculiarities of mucinous colorectal carcinoma.
Br J Surg, 72 (1985), pp. 715-718
[54.]
W.W. Walton Jr., P.F. Hagihara, W.O. Griffen Jr..
Colorectal adenocarcinoma in patients less than 40 years old.
Dis colon Rectum, 19 (1976), pp. 529-534
[55.]
A. Abad, A. Font, C. Martín.
Factores pronósticos del cáncer de colon y recto.
Rev Cancer, 11 (1997), pp. 43-53
[56.]
A. Codina, B. Ruiz, F. Fernández, J.A. Salva, J. Fernández-Llamazares.
Análisis de factores pronósticos en el cáncer colorrectal.
Cir Esp, 4 (1990), pp. 403-409
[57.]
L. Hedrick, K.R. Cho, J. Boyd, B. Vogelstein.
The role of the DCC gene in tumorigenesis.
CRC, 1 (1992), pp. 90-95
Copyright © 2001. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos